Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral salmon calcitonin for osteoporosis in postmenopausal women
2005-002984-10Phase 3Completed
- Sponsor
- Nordic Bioscience
- Start
- Jul 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in osteoporosis comparing Oral salmon calcitonin 0.8 mg with Placebo (2 arms). Started Jul 2005; status: completed.
02
Drugs
calcitonin salmon
03
Conditions
osteoporosis
Beyond the preview
Go deeper on 2005-002984-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002984-10.